Jeremy Chrisp

Fondateur chez EpiAxis Therapeutics Pty Ltd.

Profil

Dr. Jeremy Chrisp has over 21 years experience in the Australian healthcare market as a scientist, marketer, senior manager, consultant and entrepreneur in the pharmaceutical, medical device and life-science fields.
He gained this experience by working with leading global multinational companies, including Merck & Co, Stryker, Becton Dickinson & Medtronic.
Dr. Chrisp held positions including clinical research associate, sales representative, and product manager, marketing manager, business development manager, sales and marketing manager as well as managing director.
Until recently, he was the CEO of Medsaic Pty Ltd, a spin-out company from The University of Sydney that commercialised a new antibody micro-array platform for the diagnosis of disease by the identification of surface proteins.
He is also the founder and Managing Director of Jeremy Chrisp & Associates, a biotechnology consultancy company with a focus on start-up ventures.
Dr. Chrisp has extensive market experience: including both capital equipment and single use medical devices, diagnostics, surgical implants and therapeutics, covering disciplines such as anaesthetics, general surgery, minimally invasive surgery, orthopaedics, cardiology, respiratory medicine, immunology and ophthalmology.
Jeremy holds a B.Sc (Hons) in physiology from the University of Otago (NZ) and PhD in physiology from the University of Canterbury (NZ).
He is also a member of the Australian Institute of Company Directors.

Postes actifs de Jeremy Chrisp

Sociétés	Poste	Début
Beta Therapeutics Pty Ltd.	Directeur/Membre du Conseil	-
EpiAxis Therapeutics Pty Ltd.	Fondateur	-

Anciens postes connus de Jeremy Chrisp

Sociétés	Poste	Fin
ANU Connect Ventures Pty Ltd.	Private Equity Investor	-